INITIAL EXPERIENCE WITH A NEW TRANSVENOUS DEFIBRILLATION SYSTEM

被引：24

作者：

TRAPPE, HJ ^{[1
]}

KLEIN, H ^{[1
]}

FIEGUTH, HG ^{[1
]}

KIELBLOCK, B ^{[1
]}

WENZLAFF, P ^{[1
]}

LICHTLEN, PR ^{[1
]}

机构：

[1] UNIV HOSP HANNOVER,DEPT CARDIOVASC SURG,W-3000 HANNOVER 61,GERMANY

来源：

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1993年 / 16卷 / 01期

关键词：

ENDOCARDIAL LEAD SYSTEMS; CARDIOVERTER DEFIBRILLATOR;

D O I：

10.1111/j.1540-8159.1993.tb01550.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The clinical efficacy and safety of a new bidirectional transvenous defibrillation endocardial lead system (ELS) was studied in 39 patients with ventricular tachycardia (VT) or fibrillation (VF). There were 28 patients with coronary disease and 11 patients with nonischemic VT/VF. Fourteen patients received the ELS combined with antitachycardia pacing devices (Ventak PRx 1700, CPI) and 25 patients with the Ventak P or P2 (CPI). Implantation of the ELS was attempted in 47 patients. Intraoperatively, the mean defibrillation threshold (DFT) was > 25 joules in five patients and no reliable ELS position was found in three other patients. These eight patients underwent thoracotomy and epicardial leads implantation. The mean DFT was less-than-or-equal-to 20 joules in all 39 patients and the mean DFT was 18 joules. During the mean follow-up of 8 +/- 2 months two patients (5%) died suddenly. Complications occurred in two patients (5%).

引用

页码：134 / 140

页数：7

共 10 条

[1] RESULTS AND REALISTIC EXPECTATIONS WITH TRANSVENOUS LEAD SYSTEMS [J].

BLOCK, M ;

HAMMEL, D ;

ISBRUCH, F ;

BORGGREFE, M ;

WIETHOLT, D ;

HACHENBERG, T ;

SCHELD, HH ;

BREITHARDT, G .

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (04) :665-670

[2] IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) - A NEW LEAD-SYSTEM USING TRANSVENOUS-SUBCUTANEOUS APPROACH IN PATIENTS WITH PRIOR CARDIAC-SURGERY [J].

HAMMEL, D ;

BLOCK, M ;

HACHENBERG, T ;

BORGGREFE, M ;

BUDDE, T ;

SOEPARWATA, R ;

KONERTZ, W ;

HIEF, C ;

GEYWITZ, HJ ;

BREITHARDT, G ;

SCHELD, HH .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1991, 5 (06) :315-318

[3] ASSESSMENT OF THE DEFIBRILLATION THRESHOLD AND APPROPRIATE SENSING DURING CARDIOVERTER DEFIBRILLATOR IMPLANTATION [J].

JORDAENS, L .

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (04) :636-641

[4]

MCCOWAN R, 1991, AUTOMATIC IMPLANTABL, V17, P415

[5] FACTORS ASSOCIATED WITH IMPLANTATION-RELATED COMPLICATIONS [J].

MEESMANN, M .

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (04) :649-653

[6] THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - AN OVERVIEW [J].

MIROWSKI, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (02) :461-466

[7] SURVIVAL AFTER IMPLANTATION OF THE CARDIOVERTER DEFIBRILLATOR [J].

NEWMAN, D ;

SAUVE, MJ ;

HERRE, J ;

LANGBERG, JJ ;

LEE, MA ;

TITUS, C ;

FRANKLIN, J ;

SCHEINMAN, MM ;

GRIFFIN, JC .

AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (09) :899-903

[8] PATIENTS WITH A HIGH DEFIBRILLATION THRESHOLD - CLINICAL CHARACTERISTICS, MANAGEMENT, AND OUTCOME [J].

PINSKI, SL ;

VANERIO, G ;

CASTLE, LW ;

MORANT, VA ;

SIMMONS, TW ;

TROHMAN, RG ;

WILCOFF, BL ;

MALONEY, JD .

AMERICAN HEART JOURNAL, 1991, 122 (01) :89-95

[9]

SAKSENA J, 1991, INTERVENTIONAL ELECT, P395

[10] ENDOCARDIAL LEAD SYSTEMS FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS - UNCERTAIN PROGRESS BEYOND BASE CAMP [J].

SAKSENA, S .

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (02) :123-125

← 1 →